Skip to main content

Table 1 Characteristics of patients with invasive disease due to nontypeable and encapsulated Streptococcus pneumoniae, South Africa, 2003–2013

From: Genomic analysis of nontypeable pneumococci causing invasive pneumococcal disease in South Africa, 2003–2013

Characteristic

 

Nontypeable S. pneumoniae

Encapsulated S. pneumoniae

Total

  

N = 39

N = 32785

N = 32824

  

n (%)

n (%)

n (%)

Year

2003

2 (5)

2885 (9)

2887 (9)

 

2004

4 (10)

3465 (11)

3469 (11)

 

2005

5 (13)

3643 (11)

3648 (11)

 

2006

5 (13)

3411 (10)

3416 (10)

 

2007

2 (5)

3318 (10)

3320 (10)

 

2008

6 (15)

3319 (10)

3325 (10)

 

2009

7 (18)

3377 (10)

3384 (10)

 

2010

3 (8)

2869 (9)

2872 (9)

 

2011

0

2409 (7)

2409 (7)

 

2012

3 (8)

2158 (7)

2161 (7)

 

2013

2 (5)

1931 (6)

1933 (6)

Gender

Male

23 (59)

15842 (48)

15865 (48)

 

Female

16 (41)

16291 (50)

16307 (50)

 

Unknown

0

652 (2)

652 (2)

Age group (years)

<5

17 (44)

9446 (29)

9463 (29)

 

5–14

3 (8)

2960 (9)

2963 (9)

 

15–24

2 (5)

1918 (6)

1920 (6)

 

25–44

10 (26)

11714 (36)

11724 (36)

 

45–64

4 (10)

4355 (13)

4359 (13)

 

>64

2 (5)

1137 (3)

1139 (3)

 

Unknown

1 (3)

1255 (4)

1256 (4)

Specimen type

Cerebrospinal fluid

11 (28)

11486 (35)

11497 (35)

 

Blood

22 (56)

19284 (59)

19306 (59)

 

Othera

6 (16)

2015 (6)

2021 (6)

PCV vaccinationb

Yesc

2 (100)

580 (77)

582 (77)

 

No

0

131 (17)

131 (17)

 

Unknown

0

46 (6)

46 (6)

PCV13 serotypesd

PCV13 serotypes

13e (59)

23619 (72)

23632 (72)

 

Non PCV13 serotypes

9e (41)

9166 (28)

9175 (28)

HIV status

Positive

5 (13)

7718 (23)

7723 (23)

 

Negative

5 (13)

2489 (8)

2494 (8)

 

Unknown

29 (74)

22578 (69)

22607 (69)

Immuno compromising conditionsf

Yes

2 (5)

3114 (10)

3116 (10)

 

No

13 (33)

6974 (21)

6987 (21)

 

Unknown

24 (62)

22697 (69)

22721 (69)

Comorbid conditionsg

Yes

2 (5)

1496 (5)

1498 (5)

 

No

13 (33)

8592 (26)

8605 (26)

 

Unknown

24 (62)

22697 (69)

22721 (69)

Outcome

Died

4 (10)

4024 (12)

4028 (12)

 

Recovered

14 (36)

9887 (30)

9901 (30)

 

Unknown

21 (54)

18874 (58)

18895 (58)

  1. aOther specimen types: pleural, joint and vitreous fluid
  2. bOnly children born after February 2009 were included
  3. cReceived at least 1 dose of the vaccine
  4. dPCV13 serotypes: 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 5, 7F, 3, 6A and 19A
  5. eNontypeable predicted ancestral serotypes for Group I isolates
  6. fImmunocompromising conditions were defined as medical record-documented pre-existing history of head injury, connective tissue disease, asplenia, pregnancy, premature birth, malignancy, burns, gastric acid suppression, aplastic anemia, organ transplant, primary immunodeficiency conditions, chromosomal conditions, protein energy malnutrition, alcohol dependency, current smoking, or immunosuppressive therapy
  7. gComorbid conditions were defined as medical record-documented pre-existing history of pulmonary disease, renal disease, cerebrovascular accident, hepatic disease, cardiac disease, or diabetes mellitus